The diagnostic efficacy of metagenomic next-generation sequencing (mNGS) in pathogen identification of pediatric pneumonia using bronchoalveolar lavage fluid (BALF): A systematic review and meta-analysis

被引:0
作者
Ruan, Zhifang [1 ]
Shi, Hongjin [2 ]
Chang, Lingdan [1 ]
Zhang, Jinsong [2 ]
Fu, Mengli [1 ]
Li, Rui [1 ]
Zeng, Dan [2 ]
Yang, Yuan [1 ]
Li, Ran [1 ]
Ai, Li [1 ]
Wang, Yan [3 ]
Hai, Bing [1 ]
机构
[1] Kunming Med Univ, Affiliated Hosp 2, Dept Resp & Crit Care Med, 374 Dianmian Rd, Kunming 650101, Yunnan, Peoples R China
[2] Kunming Med Univ, Affiliated Hosp 2, Dept Urol, 374 Dianmian Rd, Kunming 650101, Yunnan, Peoples R China
[3] Panlong Dist Peoples Hosp, Dept Resp Med, 13 Yuanbo Rd, Kunming 650225, Yunnan, Peoples R China
关键词
Pediatric pneumonia; Metagenomic next-generation sequencing; (mNGS); Etiological diagnosis; Diagnostic performance; COMMUNITY-ACQUIRED PNEUMONIA; TESTS;
D O I
10.1016/j.micpath.2025.107492
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: This meta-analysis evaluates and compares the diagnostic efficacy of metagenomic next-generation sequencing (mNGS) with conventional microbiological tests (CMTs) in diagnosing pediatric pneumonia using bronchoalveolar lavage fluid (BALF). Methods: Data were sourced from Embase, PubMed, Web of Science, and the Cochrane Library. The pooled positive detection rate (PDR) of pathogens was estimated using fixed-effects or random-effects models. Subgroup analyses explored factors influencing mNGS diagnostic performance. Data analysis was conducted using Review Manager (RevMan) 5.4 and Stata version 16.0. Results: The pooled PDR of mNGS was 85.83 %, which is higher than the pooled PDR of 49.97 % for CMTs. A random-effects model indicated that, compared to CMTs, mNGS has a significantly higher PDR in pediatric pneumonia (OR = 3.99, 95 %CI: 2.12-7.50, P G 0.0001, I2 = 81 %). Subgroup analysis indicated that mNGS exhibited greater advantages in the group using the QIAamp kit (OR = 5.55, 95 % CI: 3.03-10.16, P G 0.00001), the group using the Illumina Nextseq platform (OR = 4.87, 95 % CI: 2.97-7.99, P G 0.00001), the DNA-only mNGS group (OR = 4.54, 95 % CI: 2.73-7.54, P G 0.00001), and the non-severe pneumonia group (OR = 4.76, 95 % CI: 3.51-6.46, P G 0.00001). However, when the subgroups were categorized as mixed infections or single-pathogen infections, no statistically significant differences were observed (Mixed: OR = 1.77, 95 % CI: 0.30-10.56, P = 0.53; Single: OR = 3.97, 95 % CI: 0.42-37.87, P = 0.23) Conclusion: mNGS demonstrates high diagnostic efficacy in detecting pathogens in BALF from pediatric patients with pneumonia. The diagnostic stability of mNGS is influenced by sample extraction, sequencing platforms, positive interpretation criteria, and disease status. Standardized procedures and technologies can enhance mNGS diagnostic performance.
引用
收藏
页数:11
相关论文
共 40 条
[1]  
Aliberti S, 2021, LANCET, V398, P906, DOI 10.1016/S0140-6736(21)00630-9
[2]   Clinical metagenomics [J].
Chiu, Charles Y. ;
Miller, Steven A. .
NATURE REVIEWS GENETICS, 2019, 20 (06) :341-355
[3]   Viral pathogen discovery [J].
Chius, Charles Y. .
CURRENT OPINION IN MICROBIOLOGY, 2013, 16 (04) :468-478
[4]   Comparing Apples and Oranges?: Next Generation Sequencing and Its Impact on Microbiome Analysis [J].
Clooney, Adam G. ;
Fouhy, Fiona ;
Sleator, Roy D. ;
Driscoll, Aisling O' ;
Stanton, Catherine ;
Cotter, Paul D. ;
Claesson, Marcus J. .
PLOS ONE, 2016, 11 (02)
[5]   Towards standards for human fecal sample processing in metagenomic studies [J].
Costea, Paul I. ;
Zeller, Georg ;
Sunagawa, Shinichi ;
Pelletier, Eric ;
Alberti, Adriana ;
Levenez, Florence ;
Tramontano, Melanie ;
Driessen, Marja ;
Hercog, Rajna ;
Jung, Ferris-Elias ;
Kultima, Jens Roat ;
Hayward, Matthew R. ;
Coelho, Luis Pedro ;
Allen-Vercoe, Emma ;
Bertrand, Laurie ;
Blaut, Michael ;
Brown, Jillian R. M. ;
Carton, Thomas ;
Cools-Portier, Stephanie ;
Daigneault, Michelle ;
Derrien, Muriel ;
Druesne, Anne ;
de Vos, Willem M. ;
Finlay, B. Brett ;
Flint, Harry J. ;
Guarner, Francisco ;
Hattori, Masahira ;
Heilig, Hans ;
Luna, Ruth Ann ;
Vlieg, Johan van Hylckama ;
Junick, Jana ;
Klymiuk, Ingeborg ;
Langella, Philippe ;
Le Chatelier, Emmanuelle ;
Mai, Volker ;
Manichanh, Chaysavanh ;
Martin, Jennifer C. ;
Mery, Clementine ;
Morita, Hidetoshi ;
O'Toole, Paul W. ;
Orvain, Celine ;
Patil, Kiran Raosaheb ;
Penders, John ;
Persson, Soren ;
Pons, Nicolas ;
Popova, Milena ;
Salonen, Anne ;
Saulnier, Delphine ;
Scott, Karen P. ;
Singh, Bhagirath .
NATURE BIOTECHNOLOGY, 2017, 35 (11) :1069-+
[6]   A comprehensive benchmarking study of protocols and sequencing platforms for 16S rRNA community profiling [J].
D'Amore, Rosalinda ;
Ijaz, Umer Zeeshan ;
Schirmer, Melanie ;
Kenny, John G. ;
Gregory, Richard ;
Darby, Alistair C. ;
Shakya, Migun ;
Podar, Mircea ;
Quince, Christopher ;
Hall, Neil .
BMC GENOMICS, 2016, 17
[7]  
de Benedictis FM, 2020, LANCET, V396, P786, DOI 10.1016/S0140-6736(20)31550-6
[8]   Diagnostic value of bronchoalveolar lavage fluid metagenomic next-generation sequencing in pediatric pneumonia [J].
Deng, Wenhua ;
Xu, Huan ;
Wu, Yabin ;
Li, Jie .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
[9]   Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infections [J].
Diao, Zhenli ;
Han, Dongsheng ;
Zhang, Rui ;
Li, Jinming .
JOURNAL OF ADVANCED RESEARCH, 2022, 38 :201-212
[10]   Factors associated with unknown aetiology in patients with community-acquired pneumonia [J].
Ewig, S ;
Torres, A ;
Marcos, MA ;
Angrill, J ;
Rañó, A ;
de Roux, A ;
Mensa, J ;
Martínez, JA ;
de la Bellacasa, JP ;
Bauer, T .
EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (05) :1254-1262